Navigation Links
uniQure Named to MIT Technology Review's 2013 50 Disruptive Companies List Recognizing World's Most Innovative Companies
Date:2/20/2013

6;rn Aldag, CEO of uniQure. "As one of the world's leading technology publications, MIT Technology Review has consistently succeeded in picking the technology and science leaders of the future - disruptive innovators today and household names tomorrow. We believe that uniQure's advances will have a significant impact on the field of gene therapy. The power and promise of gene therapy that inspire us every day are to provide permanent relief for a broad range of diseases, instead of symptomatic treatments. Gene therapy has the potential to transform the lives of millions of patients who cannot be treated today, and it harbors the promise to prevent disease in the future. As such gene therapy constitutes a real paradigm shift."

uniQure and the other honorees will be featured in the March/April edition of MIT Technology Review, available on newsstands worldwide March 5, and online at technologyreview.com on February 20.

About uniQure

uniQure is the world leader in the development of human gene based therapies. uniQure's Glybera, a gene therapy for the treatment of lipoprotein lipase deficiency has been approved in the European Union, and is the first approved gene therapy in the Western world. uniQure's product pipeline of gene therapy products in development comprise hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design the world's first stable and scalable AAV manufacturing platform, validated in the approval process of Glybera. This proprietary platform can be applied to a large number of rare (orphan) diseases caused by one faulty gene. uniQure's largest shareholders are Forbion Capital Partners and Gilde Healthcare, two of the leading life sciences venture capital firms in the Netherlands'/>"/>

SOURCE uniQure
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. uniQure Collaborates with UCSF on GDNF Gene Therapy in Parkinsons Disease
2. uniQure Appoints Philip Astley-Sparke President US
3. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
4. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual StevieĀ® Awards for Women in Business
5. Sequenom Named to NASDAQ Global Select Market
6. U of Toronto experiment named top breakthrough of 2011 by Physics World
7. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
8. Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine
9. Royals Batter Billy Butler Named Hutch Award Winner
10. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
11. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MN (PRWEB) May 28, 2015 ... it a point to ask his audiences if ... future trends including robotics, solar cells, fuel cells, ... 3D printers, advanced battery storage technology, driverless cars, ... and high-quality but inexpensive online education. , ...
(Date:5/28/2015)... MA (PRWEB) May 28, 2015 ... located in Basel, Switzerland, and the Alliance ... a Cambridge, Massachusetts-based non-profit organization operating in ... a global system to enhance quality, safety, ... development and health research, are pleased to ...
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
(Date:5/27/2015)... Israel , May 27, 2015  Tikcro Technologies ... quarter ended March 31, 2015. ... quarter, we continued pre-clinical work to generate functional specific ... an early stage, we are encouraged by the development ... field as new antibodies which modulate immune checkpoints gain ...
Breaking Biology Technology:Futurist Jack Uldrich to Deliver 4 Keynote Addresses in June 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3
... on terror includes fighting the dark side of deadly ... Raushel is helping with the fight by developing an ... organophosphates. , Synthetic organophosphates started their journey as insecticides ... the dangerous alleys of chemical warfare during World War ...
... team are researching nano-scale cantilevers that have the potential to ... the air. Put them into a small handheld device and ... in industry, in health care and even at home. , ... work has been something we,ve only seen so far in ...
... Although naturally occurring smallpox was eradicated in 1977, ... a laboratory and release it into the population. Under ... insufficient for universal administration. In a study published in ... of Medicine , researchers found that lifetime protection is ...
Cached Biology Technology:Researcher working on destruction of chemical weapons 2Clemson researchers advance nanoscale electromechanical sensors 2New study indicates smallpox vaccination effective for decades 2
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/21/2015)... , May 21, 2015 The Sync ... of music for health, today announced a collaborative partnership ... The partnership will center on collaboration on original research, ... first step in the collaboration, The Sync Project and ... "Music as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... , May 20, 2015 NXT-ID, Inc. ... that its wholly owned subsidiary, 3D-ID LLC, a company ... Team Battelle for the biometrics technology portion of the ... Contract from the Department of the Army. ... products developed for government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... Cincinnati (UC) have identified key molecular components linking circadian ... , providing insights that could lead to improved disease ... the UC College of Medicine Department of Molecular and ... findings Monday, Jan. 13, online ahead of print in ...
... of Illinois study has identified the three most significant risk ... a parental BMI that classifies the mom or dad as ... eating in order to control his weight. "We looked ... of child obesity, and the three that emerged as strong ...
... concentrations of serum long-chain omega-3 fatty acids may help reduce ... of Eastern Finland study published recently in Diabetes Care ... fish oils. Type 2 diabetes is becoming increasingly widespread ... risk factor, which means that diet and other lifestyle factors ...
Cached Biology News:Researchers identify key components linking circadian rhythms and cell division cycles 2Illinois study identifies 3 risk factors most highly correlated with child obesity 2Fish derived serum omega-3 fatty acids help reduce the risk of type 2 diabetes 2
Sheep polyclonal to Trenbolone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule: 17 alpha Trenbolone(3)-BTG....
... chain (human), clone 41D GenBank ... : Native clusterin purified from human ... 0.15M NaCl and 0.05% sodium azide ... lysates from HeLa cells or MCF-7 ...
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Chlamydia pneumoniae (TWAR)...
Biology Products: